Grandfield & Dodd’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15,113
Closed -$3.21M 200
2023
Q3
$3.21M Sell
15,113
-235
-2% -$46.9K 0.24% 64
2023
Q2
$2.95M Sell
15,348
-55
-0.4% -$10.9K 0.21% 68
2023
Q1
$3.12M Buy
15,403
+257
+2% +$41.2K 0.22% 70
2022
Q4
$1.95M Buy
15,146
+394
+3% +$50.8K 0.14% 76
2022
Q3
$2.02M Buy
14,752
+50
+0.3% +$8.15K 0.16% 74
2022
Q2
$2.6M Sell
14,702
-7
-0% -$1.01K 0.2% 70
2022
Q1
$2.12M Buy
14,709
+269
+2% +$36.4K 0.14% 76
2021
Q4
$2.23M Buy
14,440
+426
+3% +$71.3K 0.14% 76
2021
Q3
$2.38M Sell
14,014
-795
-5% -$124K 0.17% 72
2021
Q2
$2.34M Buy
14,809
+15
+0.1% +$2.23K 0.16% 72
2021
Q1
$2.05M Buy
14,794
+68
+0.5% +$11K 0.15% 73
2020
Q4
$2.58M Buy
14,726
+101
+0.7% +$18.8K 0.2% 69
2020
Q3
$2.86M Buy
14,625
+69
+0.5% +$11.6K 0.26% 67
2020
Q2
$2.47M Buy
14,556
+465
+3% +$69.4K 0.24% 67
2020
Q1
$1.63M Buy
14,091
+281
+2% +$31.1K 0.19% 71
2019
Q4
$1.58M Buy
13,810
+575
+4% +$61K 0.14% 80
2019
Q3
$1.13M Buy
13,235
+1,010
+8% +$74K 0.11% 87
2019
Q2
$846K Buy
12,225
+765
+7% +$53.6K 0.08% 100
2019
Q1
$839K Buy
11,460
+145
+1% +$10.3K 0.09% 102
2018
Q4
$641K Buy
11,315
+144
+1% +$9.03K 0.08% 108
2018
Q3
$862K Buy
11,171
+95
+0.9% +$7K 0.09% 104
2018
Q2
$735K Buy
11,076
+70
+0.6% +$4.01K 0.08% 110
2018
Q1
$576K Sell
11,006
-350
-3% -$19.1K 0.06% 116
2017
Q4
$608K Buy
11,356
+270
+2% +$15.8K 0.06% 120
2017
Q3
$603K Buy
11,086
+1,085
+11% +$55.5K 0.07% 118
2017
Q2
$517K Buy
10,001
+495
+5% +$31.5K 0.06% 130
2017
Q1
$598K Buy
9,506
+95
+1% +$5.93K 0.07% 113
2016
Q4
$497K Buy
9,411
+830
+10% +$49.9K 0.06% 123
2016
Q3
$463K Buy
8,581
+580
+7% +$27.5K 0.06% 124
2016
Q2
$323K Buy
8,001
+413
+5% +$15.7K 0.05% 144
2016
Q1
$266K Buy
+7,588
New +$255K 0.04% 149

Other funds holding SGEN

Grandfield & Dodd's SGEN Position: Q4 2023 in Review

Grandfield & Dodd sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 15,113 shares — an estimated $3.21M sold.

Grandfield & Dodd first reported a position in SGEN in Q1 2016 and held it in 31 quarters. The position peaked at $3.21M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Grandfield & Dodd reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Grandfield & Dodd sold 15,113 Seagen Inc. Common Stock shares in Q4 2023, an estimated $3.21M.
  • Grandfield & Dodd first reported a position in Seagen Inc. Common Stock in Q1 2016 and held it in 31 quarters.
  • Grandfield & Dodd's Seagen Inc. Common Stock position peaked at $3.21M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Grandfield & Dodd's 13F filing for Q4 2023, filed 31 Jan 2024.